Male patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation became aware that post-aquablation, while in the post anesthesia care unit (pacu), the patient was administered a blood transfusion due to bleeding (per the manufacturer's instructions for use, bleeding is listed as a perioperative risk of the aquablation).The patient was taken back to the operating room for cauterization to address the bleeding and sent home five (5) days post-aquablation procedure.No adverse health consequences were reported with the patient due to this event.No malfunction of the aquabeam robotic system was reported.
|
H.10 additional manufacturer narrative: the aquabeam robotic system was not returned for investigation of this event and is currently in use at the user facility.The investigation consisted of a review of the information received through the treating physician, a review of the device history record, log files, labeling and similar events reported to procept.A review of the device history record (dhr) for serial number (b)(6) was performed, which confirmed that there were no nonconformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.The aquabeam robotic system's log file was reviewed, which confirmed no malfunctions during the aquablation procedure.The review of the log file indicated that the system functioned as designed.Aquabeam robotic system instructions for use (ifu), ifu0101-00, rev.E, was reviewed and states the following: 4.3.Warnings: procedure.As with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: o bleeding.A review for similar complaints under (b)(4) rev.G/serial number (b)(6) confirmed no other similar events reported to procept.A review of similar complaints across all systems confirmed a total of 27 similar events.A root cause for the reported event could not be determined.The aquabeam robotic system's ifu lists bleeding as a potential risk of the aquablation procedure.Based on the review of the log file, ifu, and dhr the event is considered not to be device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|